Legend Biotech Debt-to-Assets Ratio Growth & History (LEGN)

Legend Biotech's debt-to-assets ratio was 0.24 for fiscal 2025.

View full Legend Biotech company overview

Legend Biotech annual debt-to-assets ratio history

Legend Biotech annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.240.06+33.12%
20242024-12-310.180.02+11.45%
20232023-12-310.16−0.04−21.75%
20222022-12-310.210.10+88.31%
20212021-12-310.110.10+2236.96%
20202020-12-310.00−0.02−77.91%
20192019-12-310.02

Legend Biotech debt-to-assets ratio trends

Over the last five fiscal years, Legend Biotech's debt-to-assets ratio increased from 0.00 to 0.24, a change of 0.23. The latest reported quarter, Q2 2026, shows 0.16.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Legend Biotech source filings ↗

Community posts

It’s quiet here.

No posts about LEGN yet. Start the conversation.

Write the first post